We denied an inappropriate Wegovy request (due to no qualifying criteria) and guided an atopic dermatitis case to a clinically appropriate formulary alternative—together saving $30K+ while protecting patient safety.
Download Preventing Inappropriate GLP-1 Use and High-Cost Specialty Waste to Save Over $30K
Preventing Inappropriate GLP-1 Use & Specialty Waste
Case Studies Request
Fill out the form below to receive your case study! It will be downloaded immediately after submission.